Remove 2015 Remove Clinical Trials Remove Epilepsy Remove Patients
article thumbnail

MMJ Laws In Texas: Your Complete Guide

MMJ Recs

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52
article thumbnail

Global Medical Cannabis Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

Cannabis Law Report

The global medical cannabis market exhibited strong growth during 2015-2020. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. 12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications. during 2021-2026. Companies Mentioned.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How medical marijuana could help you find the ‘new you’ in the New Year

Canna Care Docs

The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. The following is a list of some, but not all, of the most common conditions and diseases it is used to treat. Chronic pain.

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94
article thumbnail

Press Release: MAPS is Granted Innovation Passport in United Kingdom for MDMA as an Adjunct to Therapy for PTSD

Cannabis Law Report

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. It is estimated that, in 2015, 3% of people in the UK were living with PTSD. Berra Yazar-Klosinski, Ph.D.

Therapy 52
article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.

article thumbnail

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.